Identification of factors influencing the response of antiretroviral treatment;Identification de facteurs influençant la réponse à un traitement antirétroviral combiné

Medecine et Maladies Infectieuses

Volumn 34, Issue 1, 2004, Pages 37-41

  Nkoghe, D ^a,b   Nnegue S ^a   Leonard P ^a   Moutschen, M ^a   Demonty, J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NONE   (Gabon)

Author keywords

Antiretroviral treatment; HIV AIDS; Therapeutic efficacy

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; PHENOTYPE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VIRUS LOAD; VIRUS STRAIN;

EID: 1642574436     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2003.07.005     Document Type: Article

References (16)

1. Koot M., Keet I.P.M., Vos A.H.V., et al. Prognostic value of syncytium inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med. 118:1993;681-688.
2. Tersmette M., Lange J.M., de Goede R.E., et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet. 1:1989;983-985.
3. Spijkerman I., de Wolf F., Langendam M., Schuitemaker H., Coutinho R. Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDS. JID. 178:1998;397-403.
4. Paredes R., Mocroft A., Kirk O., et al. Predictors of virological success and ensuing failure in HIV-positive patients starting highly antiretroviral therapy in Europe. Arch Intern Med. 160:2000;1123-1132. Results from the EuroSIDA Study.
5. Lucas G.M., Chaisson R.E., Moore R.D. Highly active antiretroviral therapy in a large clinic: risk factors for virological failure and adverse drug reactions. Ann Intern Med. 131:1999;81-87.
6. Fatkenheuer G.F., Theisen A., Rockstroh J. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS. 11:1997;F113-F116.
7. th Conference on Retroviruses and Opportunistic Infections, Abstract 420:1998, Feb 1-5.
8. Raise E, Rosini G, Pasquinucci S, Scarpa M, Bechi M. Efficacy and safety of efavirenz in combination with NRTI in HIV positive patients. Program and abstracts from the 7th European Conference on Clinical Aspects and Treatment of HIV-Infection, Oct 23-27, Lisbon. Abstract 526.
9. Katlama C., Clotet B., Plettenberg A., et al. The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomised, double-blind, trial. AIDS. 14:2000;781-789.
10. Khanna N., Klimkait T., Schiffer V., et al. Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. AIDS. 14:2000;791-799.
11. Nkoghe D., Léonard P., Nnégué S., Moutschen M., Demonty J. Prise en charge des patients infectés par le VIH. Expérience du CHU de Liège. Rev Med Liège. 57:(8):2002;546-551.
12. Pitchenik A.E., Fischl M.A., Dickinson G.M., Becker D.M., Fournier A.M., O'Connell. Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency syndrome state. Ann Intern Med. 98:1983;277-284.
13. David K.C., Horsburg C.R. Jr, Hasiba U., Schocket A.L., Kirkpatrick C.H. Acquired immunodeficiency syndrome in a patient with hemophilia. Ann Intern Med. 98:1983;284-286.
14. Poon M.C., Landay A., Prasthofer E.F., Stagno F. Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium intracellular infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings. Ann Intern Med. 98:1983;287-290.
15. Furrer H., Wendland T., Minder C., et al. Association of syncytium-inducing phenotype of HIV-1 with CD4 cell count, viral load and sociodemographic characteristics. AIDS. 12:1998;1341-1346.
16. Frottier J., Meynard J.-L., Morand- Joubert L., Guiguet M. Facteurs prédictifs de la réponse virologique précoce après un premier traitement par une antiprotéase, au cours de l'infection à VIH. Bull Acad Natle Med. 182:1998;981-995.